Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

  • Showing results for djordjevic mv. Search instead for Djordjevik MV (0)
1.

Providing a Science Base for the Evaluation of Tobacco Products.

Berman ML, Connolly G, Cummings KM, Djordjevic MV, Hatsukami DK, Henningfield JE, Myers M, O'Connor RJ, Parascandola M, Rees V, Rice JM, Shields PG.

Tob Regul Sci. 2015 Apr;1(1):76-93.

2.

NIH electronic cigarette workshop: developing a research agenda.

Walton KM, Abrams DB, Bailey WC, Clark D, Connolly GN, Djordjevic MV, Eissenberg TE, Fiore MC, Goniewicz ML, Haverkos L, Hecht SS, Henningfield JE, Hughes JR, Oncken CA, Postow L, Rose JE, Wanke KL, Yang L, Hatsukami DK.

Nicotine Tob Res. 2015 Feb;17(2):259-69. doi: 10.1093/ntr/ntu214. Epub 2014 Oct 21.

3.

Non-cigarette tobacco use among women and adverse pregnancy outcomes.

England LJ, Kim SY, Tomar SL, Ray CS, Gupta PC, Eissenberg T, Cnattingius S, Bernert JT, Tita AT, Winn DM, Djordjevic MV, Lambe M, Stamilio D, Chipato T, Tolosa JE.

Acta Obstet Gynecol Scand. 2010;89(4):454-64. doi: 10.3109/00016341003605719. Review.

4.

Cigarette filter-based assays as proxies for toxicant exposure and smoking behavior--a literature review.

Pauly JL, O'Connor RJ, Paszkiewicz GM, Cummings KM, Djordjevic MV, Shields PG.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3321-33. doi: 10.1158/1055-9965.EPI-09-0925. Review.

5.

Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies.

Marian C, O'Connor RJ, Djordjevic MV, Rees VW, Hatsukami DK, Shields PG.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3305-20. doi: 10.1158/1055-9965.EPI-09-1014. Review.

6.

Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.

Johnson MD, Schilz J, Djordjevic MV, Rice JR, Shields PG.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3263-304. doi: 10.1158/1055-9965.EPI-09-0965. Review.

7.

Incremental lifetime cancer risks computed for benzo[a]pyrene and two tobacco-specific N-nitrosamines in mainstream cigarette smoke compared with lung cancer risks derived from epidemiologic data.

Watanabe KH, Djordjevic MV, Stellman SD, Toccalino PL, Austin DF, Pankow JF.

Regul Toxicol Pharmacol. 2009 Nov;55(2):123-33. doi: 10.1016/j.yrtph.2009.06.007. Epub 2009 Jun 18.

8.

Nicotine content and delivery across tobacco products.

Djordjevic MV, Doran KA.

Handb Exp Pharmacol. 2009;(192):61-82. doi: 10.1007/978-3-540-69248-5_3. Review.

PMID:
19184646
9.

Monitoring the tobacco use epidemic II: The agent: Current and emerging tobacco products.

Stellman SD, Djordjevic MV.

Prev Med. 2009 Jan;48(1 Suppl):S11-5. doi: 10.1016/j.ypmed.2008.09.004. Epub 2008 Sep 20. Review.

10.

Effect of delivered dosage of cigarette smoke toxins on the levels of urinary biomarkers of exposure.

Melikian AA, Djordjevic MV, Chen S, Richie J Jr, Stellman SD.

Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1408-15.

11.

Gender differences relative to smoking behavior and emissions of toxins from mainstream cigarette smoke.

Melikian AA, Djordjevic MV, Hosey J, Zhang J, Chen S, Zang E, Muscat J, Stellman SD.

Nicotine Tob Res. 2007 Mar;9(3):377-87.

PMID:
17365769
12.

Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).

Muscat JE, Djordjevic MV, Colosimo S, Stellman SD, Richie JP Jr.

Cancer. 2005 Apr 1;103(7):1420-6.

13.

Menthol cigarettes: research needs and challenges.

Henningfield JE, Djordjevic MV.

Nicotine Tob Res. 2004 Feb;6 Suppl 1:S11-6. No abstract available.

PMID:
14982705
14.

Menthol cigarettes: setting the research agenda.

Clark PI, Gardiner PS, Djordjevic MV, Leischow SJ, Robinson RG.

Nicotine Tob Res. 2004 Feb;6 Suppl 1:S5-9. No abstract available.

PMID:
14982704
15.

Smoking reduction and tobacco-related cancers: the more things change, the more they stay the same.

Leischow SJ, Djordjevic MV.

J Natl Cancer Inst. 2004 Jan 21;96(2):86-7. No abstract available.

PMID:
14734690
16.

Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York.

Muscat JE, Britton JA, Djordjevic MV, Citron ML, Kemeny M, Busch-Devereaux E, Pittman B, Stellman SD.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1474-8.

17.

The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo.

Sellers EM, Ramamoorthy Y, Zeman MV, Djordjevic MV, Tyndale RF.

Nicotine Tob Res. 2003 Dec;5(6):891-9.

PMID:
14668073
18.

Lung cancer risk in white and black Americans.

Stellman SD, Chen Y, Muscat JE, Djordjevic MV, Richie JP Jr, Lazarus P, Thompson S, Altorki N, Berwick M, Citron ML, Harlap S, Kaur TB, Neugut AI, Olson S, Travaline JM, Witorsch P, Zhang ZF.

Ann Epidemiol. 2003 Apr;13(4):294-302.

PMID:
12684197
19.

Smoking and lung cancer risk in American and Japanese men: an international case-control study.

Stellman SD, Takezaki T, Wang L, Chen Y, Citron ML, Djordjevic MV, Harlap S, Muscat JE, Neugut AI, Wynder EL, Ogawa H, Tajima K, Aoki K.

Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1193-9.

20.

Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler.

Hurt RD, Croghan GA, Wolter TD, Croghan IT, Offord KP, Williams GM, Djordjevic MV, Richie JP Jr, Jeffrey AM.

Nicotine Tob Res. 2000 Nov;2(4):327-36.

PMID:
11197312

Supplemental Content

Loading ...
Support Center